Literature DB >> 15259012

Lack of dendritic cell maturation by the plant toxin ricin.

Daniel C Smith1, Mariolina Salio, J Michael Lord, Lynne M Roberts, Vincenzo Cerundolo.   

Abstract

Several bacterial toxins either promote or inhibit the maturation of human monocyte-derived DC. Since the potent plant toxin ricin exploits the same cell entry pathway used by these bacterial toxins and shares identical catalytic activity with some of them, we have studied the capacity of ricin to induce DC maturation in vitro. Here, we show that in contrast to the bacterial proteins, ricin neither induces DC maturation nor interferes with LPS-induced DC maturation. There is no correlation between the absence of DC maturation and ricin dysfunction. Indeed, some of the ricin variants retain significant ribotoxicity and catalytic activity. We have extended these observations to ebulin-1, suggesting that this may be a general characteristic of plant-derived cytotoxic ribosome-inactivating toxins. The human immune system may therefore have evolved to recognize and rapidly respond to the bacterial proteins, whilst being less responsive to the equivalent plant cytotoxins. Understanding the effect of ricin on professional APC may provide insights into the generation of an anti-ricin vaccine and into the use of inactivated ricin A chains as delivery vectors as part of a vaccination protocol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259012     DOI: 10.1002/eji.200425157

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells.

Authors:  Heidi A Schreiber; Jozsef Prechl; Hongquan Jiang; Alla Zozulya; Zsuzsanna Fabry; Ferencz Denes; Matyas Sandor
Journal:  J Immunol Methods       Date:  2010-02-26       Impact factor: 2.303

2.  Immunological response in mice bearing LM3 breast tumor undergoing pulchellin treatment.

Authors:  Djamile Cordeiro de Matos; Lívia Carolina Abreu de Ribeiro; Aline Tansini; Lucas Souza Ferreira; Marisa Campos Polesi Placeres; Lucas Luis Colombo; Iracilda Zeppone Carlos
Journal:  BMC Complement Altern Med       Date:  2012-07-24       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.